Filing Details
- Accession Number:
- 0001562180-22-004906
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-08 16:02:41
- Reporting Period:
- 2022-06-06
- Accepted Time:
- 2022-06-08 16:02:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1636422 | Health Catalyst Inc. | HCAT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1494174 | H. Daniel Orenstein | C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-06-06 | 2,838 | $14.85 | 103,671 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.
- Represents the weighted average sale price of the shares sold ranging from $14.62 to $15.18 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.